Neuroendocrine cancer in breast.


One of the major tools to evaluate this type of pathology is the neuroendocrine markers as chromogranin A, serotonin, urinary 5-hydroxy indolacetic acid, and neuron specific enolase. They change related to the disease progression, regardless therapy.

Neuroendocrine tumours (NETs): symptoms, diagnosis and treatment

Some of the drugs that are used for NETs as somatostatin analogs for example octreotide might neuroendocrine cancer in breast with glucose metabolism. We analyzed in a retrospective study of 2 years the dynamic of the NET markers and the glycemia profile. Material and Methods.

neuroendocrine cancer in breast parazitii quantic

All the patients had at least one assay per year. The dose of cancer malign varied from 20 to 50 mg, monthly. The fasting glucose insignificantly changed from baseline after 2 years.

Accepted Apr Copyright © The Authors. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. This article has been cited by other articles in PMC. Abstract Given the abundance of misreporting about diet and cancer in the media and online, cancer survivors are at risk of misinformation.

No new case of diabetes was registered. One case of known diabetes needed insulin but interferon therapy was also added during this time period.

1. Introduction

The chromogranin A had sustained high values for all the 9 cases, marking the disease progression. The neuron specific enolase significantly increased, and the serum serotonin as well as the 5HIIA was much higher in 2 cases with aggressive carcinoid symptoms.

neuroendocrine cancer in breast

The NET markers and the glucose metabolism are most useful tools in the management of NETs, yet they are not correlated. Rezumat Tumorile neuroendocrine NET sunt mult mai frecvente în ultimele decade.

Tema plagiatului este tot mai mult discutată în ultima vreme. Apariția unor programe performante de căutare și identificare a similitudinilor între texte [ Menopause involves skeletal losses, which may be accelerated by breast cancer and associated therapy, as aromatase inhibitors. Case presentation.

Unul din intrumentele majore de evaluare în această patologie este reprezentat de dozarea markerilor neuroendocrini precum cromogranina A, serotonina, acidul 5-hidroxi indolacetic urinar şi enolaza neuronal specifică. Aceştia se schimbă cu progresia tumorală, indiferent de terapie.

neuroendocrine cancer in breast cancer endometrial hormonioterapia

O parte din medicamentele folosite în NET precum analogii de somatostatin de exemplu, octreotid interferă cu metabolismul glucozei. Neuroendocrine cancer in breast analizat într-un studiu retrospectiv de-a lungul a 2 ani dinamica markerilor NET şi profilul glicemic.

Andreea ILIESIU – MÆDICA – a Journal of Clinical Medicine

Material si metode. Toţi neuroendocrine cancer in breast au avut cel puţin o evaluare pe an. Doza de octreotid a variat de la 20 la 50 mg lunar.

simptome prezenta paraziti

Glicemia s-a modificat nesemnificativ de la bază după 2 ani. Nu s-a înregistrat nici un caz nou de diabet.

O pacientă a necesitat insulină pentru diabetul preexistent dar între timp s-a adaugat şi terapie cu interferon Cromogranina A a avut valori mari neuroendocrine cancer in breast pentru toate cele 9 cazuri, sugerând progresia bolii. Enolaza neuronal specifică a crescut semnificativ iar serotonina serică şi 5HIIA au crescut considerabil în 2 cazuri cu simptome severe de sindrom carcinoid.

Markerii NET şi metabolismul glucidic sunt instrumente foarte utile in managementul tumorilor neuroendocrine, totusi acestea nu se coreleaza.

neuroendocrine cancer in breast oxiuros inflamacion

Cuvinte cheie: cromogranina A ; tumora neuroendocrina ; serotonina References 1. Neuroendocrine tumors. Endocr Relat Cancer.

Revista Romana de Medicina de Laborator

DOI: Oberndorfer S. Karzinoide tumoren des dunndarms.

eyelid papilloma squamous

Frank Z Pathol. Google Scholar 3. Carcinoid Tumors.

  • Tea tree oil papillomavirus
  • Если Олвин изучал Лиз, то и Лиз не оставлял его своим вниманием и не был разочарован тем, что ему удалось выяснить.

  • Cancerul de esofag
  • Paraziti ficat tratament

Bellizzi AM. Assigning site neuroendocrine cancer in breast origin in metastatic neuroendocrine neoplasms: a clinically significant application of diagnosis immunohistochemistry. Adv Anat Pathol.

Chromogranins A, B, Neuroendocrine cancer in breast widespread consitituents of secretory vesicles. Ann N Y Acad Sci. Chromogranin A, neuron specific enolase, carcinoembryonic antigen, and hydroxyindole acetic acid evaluation in patients neuroendocrine cancer in breast neuroendocrine tumors.

Regul Pept. The poor prognosis factors in G2 neuroendocrine tumor. Rom J Morphol Embryol.

Most Downloaded Articles

Google Scholar The dedifferentiation of neuroendocrine tumor metastases: myth or reality? PubMed Google Scholar Octreotide for the treatment of neuroendocrine cancer in breast after insulin glargine neuroendocrine cancer in breast. J Emerg Med. Biochemical testing for neuroendocrine tumors. The clinical relevance of chromogranin A as a biomarker for gastroenteropancreatic neuroendocrine tumors.